What is the recommended dose of amoxicillin (Amox)-clavulanate (Clav) per kg weight in neonates?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin-Clavulanate Dosing in Neonates

For neonates, the recommended dose of amoxicillin-clavulanate is 30 mg/kg/day (based on the amoxicillin component) divided every 12 hours. 1

FDA-Approved Neonatal Dosing

  • Neonates and infants aged <12 weeks (<3 months) should receive 30 mg/kg/day divided every 12 hours, based on the amoxicillin component 1
  • The 125 mg/5 mL oral suspension formulation is specifically recommended for this age group, as experience with the 200 mg/5 mL formulation is limited 1
  • The medication may be taken without regard to meals, though absorption of clavulanate is enhanced when administered at the start of a meal 1

Age-Specific Considerations for Dosing Intervals

Gestational age and postnatal age significantly affect amoxicillin clearance, which is critical for optimizing dosing:

  • In neonates born after 30 weeks' gestation, clearance increases with postnatal age: 1.25-fold by day 10 and 1.43-fold by day 20 compared to day 3 2
  • Current weight, postnatal age, and gestational age are all significant covariates affecting amoxicillin pharmacokinetics 3
  • Twice-daily dosing (50 mg/kg/day in two divided doses) is superior to three or four times daily schedules in the first week of life for achieving pharmacodynamic targets 2

Clinical Context and Efficacy Data

The twice-daily regimen achieves adequate therapeutic levels:

  • For early-onset sepsis using 25 mg/kg twice daily, 99.0% of premature neonates and 87.3% of term neonates achieve the pharmacodynamic target (time above MIC) at a MIC breakpoint of 1 mg/L 3
  • For late-onset sepsis, 25 mg/kg three times daily in premature neonates and 25 mg/kg four times daily in term neonates achieves targets at MIC breakpoint of 2 mg/L 3
  • Oral bioavailability is 87%, making oral administration a viable alternative to intravenous therapy 2

Important Caveats

Do not substitute different formulations or strengths, as they contain varying amounts of clavulanic acid:

  • The 250 mg/125 mg tablet contains 125 mg clavulanic acid, while the 250 mg/62.5 mg chewable tablet contains only 62.5 mg 1
  • Two 250 mg/125 mg tablets are not equivalent to one 500 mg/125 mg tablet due to the fixed clavulanate content 1

Twice-daily dosing reduces diarrhea compared to three-times-daily administration, improving tolerability without compromising efficacy 1, 4

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.